Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jun 29;93(S1):e2022207.
doi: 10.23750/abm.v93iS1.12760.

Acute acalculous cholecystitis as an early manifestation of COVID-19: case report and literature review

Affiliations
Review

Acute acalculous cholecystitis as an early manifestation of COVID-19: case report and literature review

Alessia D'Introno et al. Acta Biomed. .

Abstract

Background: The novel coronavirus disease 2019 (COVID-19) has rapidly spread worldwide since the outbreak in Wuhan, China, in 2019, becoming a major threat to public health. The most common symptoms are fever, dry cough, shortness of breath, but subjects with COVID-19 may also manifest gastrointestinal symptoms, and in a few cases an involvement of the gallbladder has been observed. Case report: Here we present a case of 50-year-old male with SARS-CoV-2 infection who had abdominal pain, vomiting and diarrhea without respiratory symptoms and was finally diagnosed as acute acalculous cholecystitis (AAC). Laparoscopic cholecystectomy was performed and found a gangrenous gallbladder; the real-time reverse transcription polymerase chain reaction SARS-CoV-2 nucleic acid assay of the bile was negative. We also made a review of the literature and try to understand the hypothetic role of SARS-CoV-2 in the pathogenesis of AAC. Conclusions: We highlighted that it is noteworthy to look at gastrointestinal symptoms in patients with SARS-CoV-2 infection and take into account AAC as a possible complication of COVID-19. Although more evidence is needed to better elucidate the role of the pathogenic mechanisms of the SARS-CoV-2 in AAC, it is conceivable that the hepatobiliary system could be a potential target of SARS-CoV-2.

PubMed Disclaimer

Conflict of interest statement

each author declares that he or she has no commercial associations (e.g. consultancies, stock ownership, equity interest, patent/licensing arrangement etc.) that might pose a conflict of interest in connection with the submitted article.

Figures

Figure 1.
Figure 1.
Computed Tomography images
Figure 2.
Figure 2.
40x view of hematoxylin and eosin stained sections showing a dense mixed inflammatory infiltrate rich in lymphocytes and neutrophils, edema and hemorrhagic areas of the gallbladder wall.
Figure 3.
Figure 3.
100x view of hematoxylin and eosin stained section showing gallbladder wall with low-grade inflammation, fibrosis and thickening and hypertrophy of the muscularis propria.

References

    1. Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review. JAMA. 2020;324(8):782–93. - PubMed
    1. Wong SH, Lui RN, Sung JJ. Covid-19 and the digestive system. J Gastroenterol Hepatol. 2020;35(5):744–8. - PubMed
    1. Bruni A, Garofalo E, Zuccalà V, et al. Histopathological findings in a COVID-19 patient affected by ischemic gangrenous cholecystitis. World J Emerg Surg. 2020;15:43. - PMC - PubMed
    1. Lovece A, Asti E, Bruni B, Bonavina L. Subtotal laparoscopic cholecystectomy for gangrenous gallbladderduring recovery from COVID-19 pneumonia. Int J Surg Case Rep. 2020;72:335–8. - PMC - PubMed
    1. Mattone E, Sofia M, Schembari E, et al. Acute acalculous cholecystitis on a COVID-19 patient: a case report. Ann Med Surg (Lond) 2020;58:73–5. - PMC - PubMed